Nautilus Biotechnology (NAUT) Other Gross PP&E Adjustments (2020 - 2026)

Nautilus Biotechnology has disclosed Other Gross PP&E Adjustments across 7 years of filings, most recently posting -$14.5 million for Q1 2026.

• Other Gross PP&E Adjustments for Q1 2026 came in at -$14.5 million, up 10.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.5 million (up 10.85% YoY), and the FY2025 annual result was -$22.5 million, up 2.07% from the prior year.
• Other Gross PP&E Adjustments came in at -$14.5 million for Q1 2026 at Nautilus Biotechnology, up from -$22.5 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of -$13.4 million in Q3 2025 to a low of -$28.4 million in Q1 2023.
• The 5-year median for Other Gross PP&E Adjustments is -$22.3 million (2022), against an average of -$21.6 million.
• Across the five-year window, Other Gross PP&E Adjustments tumbled 3029.69% in 2022 and increased 29.44% in 2025, its largest moves.
• Nautilus Biotechnology's Other Gross PP&E Adjustments stood at -$26.2 million in 2022, then slipped by 6.53% to -$27.9 million in 2023, then advanced by 17.73% to -$23.0 million in 2024, then climbed by 2.07% to -$22.5 million in 2025, then surged by 35.4% to -$14.5 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$14.5 million (Q1 2026), -$22.5 million (Q4 2025), and -$13.4 million (Q3 2025), per Business Quant data.